CSL Research Acceleration Initiative
CSL’s Research Acceleration Initiative aims to fast-track discovery of innovative biotherapies through partnerships between CSL and global research organizations.
The 2021 Research Acceleration Initiative will focus on research projects that span a CSL Therapeutic Area and a Focus Area, and that are amenable to or include a Modality listed below:
Therapeutic Area (emphasis on rare disease):
- Immunology
- Hematology
- Respiratory
- Cardiovascular/Metabolic
- Transplant
Focus Areas:
- Novel drug targets
- Novel therapeutic candidates
- Novel strategies for treating disease
Modalities:
- Antibodies
- Recombinant proteins
- Cell and gene therapies
- Small molecules not of interest
Successful applicants will receive up to $200K per year for 2 years (max $400K funding).
Researchers who wish to apply are required to submit a 300 word online pre-application by Feb. 25 to Sharon Ross (University City Science Center) at [email protected] Shortlisted applicants will then be invited to submit a detailed proposal in April.
Timeline:
Feb. 25: Deadline for “paper form” pre-applications (nonconfidential, 300-word project descriptions) due to Science Center
March 12: Deadline for CSL- approved/accepted pre-applications to apply to RAI on-line portal
April 19: Selected applicants invited to submit a full application
May 16: Full application deadline for selected applicants